Long COVID and Heart Rate Problems: Tachycardia, POTS, and Palpitations

When discussing heart rate dysregulation in the context of Long COVID, it is essential to understand the specific terminology used by medical professionals. Tachycardia refers to an abnormally fast resting heart rate, typically defined as over 100 beats per minute in adults. In Long COVID, this rapid heart rate is often accompanied by palpitations, which patients describe as a fluttering, pounding, or irregular heartbeat sensation in their chest or neck. These symptoms can occur entirely out of the blue, even when a patient is resting quietly, but they are most frequently triggered by changes in posture or mild physical exertion.

For many Long COVID patients, these heart rate abnormalities culminate in a diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS). POTS is a specific form of dysautonomia characterized by an excessive increase in heart rate—specifically, a jump of 30 beats per minute or more (or 40 bpm for teenagers)—within ten minutes of standing up from a lying down position. Unlike standard orthostatic hypotension, this heart rate spike occurs without a significant drop in blood pressure. You can learn more about the fundamentals of this condition in our comprehensive Understanding POTS: Postural Orthostatic Tachycardia Syndrome Explained guide.

What makes post-COVID tachycardia uniquely challenging is its sudden onset in previously healthy, often highly active individuals. Patients who once ran marathons or worked demanding physical jobs suddenly find themselves unable to stand long enough to take a shower or cook a meal. The British Journal of General Practice notes that this profound shift is not a sign of cardiovascular deconditioning from bed rest, but rather a complex neurological and vascular injury caused by the virus. The severity of these symptoms often fluctuates unpredictably, making it incredibly difficult for patients to plan their daily lives or maintain employment.

In Long COVID, tachycardia and POTS rarely exist in a vacuum; they are almost always accompanied by severe, debilitating fatigue and orthostatic intolerance (the inability to tolerate upright posture). When the autonomic nervous system—which controls automatic bodily functions like heart rate, blood pressure, and digestion—is damaged or dysregulated, the body has to expend massive amounts of energy just to maintain basic equilibrium. This constant internal battle drains the patient's energy reserves, leading to profound exhaustion that is not relieved by sleep or standard rest.

Furthermore, this autonomic dysfunction is deeply intertwined with post-exertional malaise (PEM), a hallmark symptom of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). PEM is a severe worsening of symptoms following even minor physical or cognitive exertion. When a Long COVID patient with POTS tries to push through their tachycardia and fatigue, they often trigger a severe autonomic crash. To understand more about how the nervous system misfires in these scenarios, explore our guide on Understanding Dysautonomia: When the Autonomic Nervous System Misfires.

The interconnected nature of these symptoms means that managing the heart rate alone is rarely sufficient. Patients must adopt a holistic approach that addresses the underlying autonomic nervous system dysfunction, the vascular abnormalities, and the profound energy deficits. By recognizing that these heart rate spikes are a physiological response to systemic stress rather than a primary cardiac defect, patients and providers can begin to implement more effective, targeted management strategies.

To truly understand why Long COVID causes such severe heart rate dysregulation, we must look at the microscopic changes occurring within the cardiovascular system. One of the most significant breakthroughs in Long COVID research comes from the work of Dr. Douglas Kell and Dr. Etheresia Pretorius, who discovered the presence of fibrinaloid microclots in the blood of Long COVID patients. Their research demonstrates that the SARS-CoV-2 spike protein interacts directly with fibrinogen in the blood, causing it to clot into an anomalous, amyloid-like structure that is highly resistant to the body's natural clot-busting processes.

These resilient microclots circulate throughout the bloodstream and become lodged in the microcapillaries, the smallest blood vessels where the vital exchange of oxygen and nutrients occurs. Because red blood cells cannot pass through these blocked capillaries, the surrounding tissues and muscles experience localized oxygen starvation, a condition known as tissue hypoxia. This microscopic vascular blockage explains why standard oxygen saturation tests (like a finger pulse oximeter) often read as normal, even while the patient's cells are desperately starved for oxygen.

The connection between this tissue hypoxia and tachycardia is a direct result of the body's survival mechanisms. When the autonomic nervous system senses that tissues are deprived of oxygen, it interprets this state as one of high physical exertion or severe stress. To compensate for the 'oxygen debt' and force blood through the blocked microcapillaries, the brain triggers an exaggerated release of adrenaline and noradrenaline. This sympathetic nervous system surge forces the heart to beat excessively fast, resulting in the severe tachycardia and palpitations characteristic of Long COVID POTS.

Alongside vascular clotting, severe immune dysfunction plays a massive role in driving Long COVID heart rate problems. COVID-19 is known to trigger intense immune responses that can lead to autoimmunity, a state where the body mistakenly produces antibodies that attack its own healthy cells and tissues. In the context of Long COVID POTS, researchers have identified specific autoantibodies that target the very receptors responsible for regulating cardiovascular function.

Studies have shown that a high percentage of Long COVID POTS patients develop autoantibodies targeting G-protein-coupled receptors (GPCRs). Specifically, research published in PubMed revealed that in a cohort of POTS patients, 100% exhibited autoantibodies against A1 adrenergic receptors, and over 55% had autoantibodies against M4 muscarinic receptors. These receptors are critical components of the autonomic nervous system, responsible for signaling blood vessels to constrict and telling the heart how fast to beat.

When these rogue autoantibodies attack or continuously stimulate the A1 adrenergic receptors, they impair the body's ability to properly constrict blood vessels in the legs upon standing (peripheral vasoconstriction). This failure causes blood to pool in the lower extremities, a state known as hypovolemia. To keep the patient from fainting due to a lack of blood flow to the brain, the heart reflexively beats much faster. This autoimmune interference directly fuels the orthostatic intolerance and racing heart rates that patients experience daily.

Recent scientific literature suggests that the microclot and autoantibody mechanisms are not mutually exclusive; in fact, they likely amplify one another in a vicious cycle. As fibrinaloid microclots persist in the bloodstream, they entrap inflammatory molecules, cytokines, and various malformed proteins. The immune system recognizes these trapped proteins as foreign threats and continuously generates autoantibodies against them, perpetuating chronic neuroinflammation and immune system hyperactivity.

This chronic inflammation and localized oxygen starvation eventually take a toll on the peripheral nervous system, leading to Small Fiber Neuropathy (SFN). SFN involves damage to the tiny, unmyelinated nerve fibers that regulate involuntary functions like heart rate, blood pressure, and sweating. Researchers theorize that the nerve damage seen in Long COVID POTS is a dual result of direct autoimmune attacks on the nerves and ischemic damage caused by microclots starving these nerve fibers of vital oxygen and nutrients.

Living with Long COVID POTS and chronic tachycardia is an intensely isolating experience, largely because the severity of the symptoms is entirely invisible to the outside world. Many patients describe the simple act of standing up as feeling like they just sprinted up a steep flight of stairs. The sudden rush of a pounding heart, the immediate lightheadedness, and the overwhelming heaviness in their limbs transform basic daily tasks into monumental physical challenges.

"It feels like my body is constantly running a marathon that I never signed up for," is a sentiment frequently echoed in patient support groups and clinical settings. Research shows patients often experience a profound sense of grief and frustration as they lose their independence. Activities that were once taken for granted—like standing in line at the grocery store, taking a warm shower, or cooking dinner—now require meticulous planning, pacing, and often, the use of mobility aids like shower chairs or rollators.

One of the most distressing aspects of Long COVID dysautonomia is that the heart rate spikes and palpitations do not only occur when standing. Many patients describe experiencing sudden, terrifying surges of adrenaline and tachycardia while lying perfectly still in bed. These inappropriate sinus tachycardia episodes can jolt patients awake from deep sleep, leaving them gasping for air and feeling as though they are experiencing a cardiac event.

This constant state of sympathetic nervous system overdrive means that the body never truly enters a state of deep, restorative rest. Patients report waking up feeling just as exhausted, if not more so, than when they went to sleep. This relentless autonomic hyperarousal fuels the chronic fatigue and brain fog that make cognitive tasks just as exhausting as physical ones. You can read more about this specific type of exhaustion in our guide, Fatigue in POTS: More Than Just Feeling Tired.

Perhaps the most validating yet frustrating part of the patient experience is the diagnostic journey. Because the mechanisms driving Long COVID tachycardia occur at a microscopic, cellular, and autoimmune level, standard cardiac testing often returns completely normal results. Echocardiograms, basic EKGs, and standard blood panels typically do not detect microclots, GPCR autoantibodies, or small fiber neuropathy.

As a result, many patients face medical gaslighting, being told by providers that their severe palpitations and dizziness are simply manifestations of anxiety or deconditioning. This dismissal adds a heavy psychological burden to an already debilitating physical illness. Finding a healthcare provider who understands the nuances of post-viral dysautonomia and recognizes that normal standard test results do not equate to a healthy autonomic nervous system is a critical turning point for many patients.

The medical community has rapidly expanded its research into the cardiovascular impacts of Long COVID, providing concrete data that validates the severe symptoms patients report. One of the most comprehensive studies to date was published in 2025 by researchers at the Karolinska Institutet in Circulation: Arrhythmia and Electrophysiology. This large-scale study evaluated 467 highly symptomatic, non-hospitalized Long COVID patients to determine the true prevalence of dysautonomia.

The findings were striking: 31% of the patients evaluated were definitively diagnosed with POTS, while an additional 27% exhibited POTS-like symptoms but just missed the strict diagnostic criteria. The study highlighted that Long COVID POTS predominantly affects middle-aged individuals, with an average age of 40, and a staggering 91% of the affected patients were female. Furthermore, the research demonstrated that those with POTS had significantly lower physical activity levels and shorter 6-minute walking distances compared to Long COVID patients without POTS, objectively quantifying their severe functional impairment.

To understand the daily burden of these heart rate abnormalities, researchers have utilized continuous monitoring technology. A pivotal study published in EP Europace utilized 24-hour Holter monitors to evaluate 120 Long COVID patients against 100 healthy controls. The continuous ECG data provided a stark visual representation of the autonomic chaos occurring within the Long COVID cohort.

The study found that Long COVID patients with POTS experienced an abrupt 30% increase in their heart rate during the first 30 minutes after waking up in the morning. Additionally, these patients suffered from an average of 1.4 significant heart rate 'spikes' (sudden increases of greater than 30 beats per minute) every single hour, compared to just 0.8 spikes per hour in the healthy control group. This data definitively proves that the palpitations and tachycardia reported by patients are frequent, measurable, and highly disruptive physiological events.

Emerging research is also uncovering specific hematological abnormalities linked to Long COVID POTS. A study published in Frontiers in Medicine investigated the role of blood platelets in post-viral dysautonomia. The researchers discovered that a significant portion of post-COVID-19 long-hauler patients with POTS exhibited platelet storage pool deficiency (δ-SPD), a condition where the blood platelets lack the necessary dense granules required for proper blood clotting and serotonin release.

This finding is particularly significant because it bridges the gap between the vascular clotting abnormalities (microclots) and the neurological symptoms (serotonin depletion affecting mood and gut motility). The presence of δ-SPD alongside elevated inflammatory biomarkers and GPCR autoantibodies strongly suggests that Long COVID POTS is not merely a functional nervous system disorder, but a complex, multi-system disease driven by profound immune and vascular pathology.

For patients managing Long COVID and POTS, tracking specific cardiovascular metrics is essential for avoiding symptom relapses and communicating effectively with healthcare providers. One of the most critical metrics to monitor is Heart Rate Variability (HRV). HRV measures the variation in time (in milliseconds) between consecutive heartbeats. Unlike your standard heart rate, which measures beats per minute, HRV provides a direct window into the health and flexibility of your autonomic nervous system.

In a healthy, resilient nervous system, HRV is generally high, indicating that the body can smoothly transition between the sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) states. However, research published in MCMC Research consistently shows that Long COVID patients have significantly reduced HRV compared to healthy controls. A chronically low HRV indicates that the nervous system is locked in a state of sympathetic dominance and systemic stress, making the body highly vulnerable to symptom flares from even minor physical or emotional triggers.

Modern wearable technology—such as smartwatches, chest straps, and specialized rings—has revolutionized how patients track their dysautonomia. A recent study published in Computing in Cardiology validated the use of calibrated smartwatches to detect POTS and autonomic dysfunction in Long COVID patients, proving that these devices can accurately capture the marked tachycardia and elevated sympathetic markers that mirror formal clinical diagnostics.

Beyond identifying POTS, wearables are invaluable tools for detecting and managing post-exertional malaise (PEM). Studies observing Long COVID patients found that while healthy individuals recover their baseline HRV within a few hours after strenuous activity, Long COVID patients often suffer suppressed HRV for 24 hours or more. By continuously tracking their HRV and resting heart rate, patients can identify when their nervous system has taken a 'hit.' A sudden drop in HRV or an unexplained spike in resting heart rate serves as an objective, early warning sign that the body requires immediate, aggressive rest to avoid a severe PEM crash.

To make the most of your tracking efforts, it is important to record data systematically and share it effectively with your medical team. Randomly checking your heart rate throughout the day can sometimes increase anxiety; instead, focus on structured tracking. We recommend performing a 'poor man's tilt table test' at home: record your heart rate and blood pressure after lying flat for 10 minutes, then stand up and record the numbers again at the 2, 5, and 10-minute marks.

Keep a simple daily log that correlates your objective data (HRV scores, morning resting heart rate, standing heart rate spikes) with your subjective experience (fatigue levels, brain fog severity, palpitations). When you bring this organized data to your healthcare provider, it transforms vague descriptions of 'feeling dizzy' into actionable, clinical evidence of orthostatic intolerance. For more insights on why standing exacerbates these symptoms, review our Orthostatic Intolerance: Why Standing Makes You Feel Worse guide.

Managing tachycardia and POTS in Long COVID requires a multi-faceted approach, and clinical consensus guidelines heavily emphasize non-pharmacological volume expansion as the first-line defense. Because hypovolemia (low blood volume) drives the compensatory heart rate spikes, patients are typically instructed to aggressively increase their fluid and sodium intake. The standard recommendation is to consume 2 to 3 liters of water daily alongside 5 to 10 grams of salt (roughly 4,000 to 5,000 mg of sodium).

However, there is a critical 'hidden danger' in this approach that many patients overlook. Aggressive salt loading forces the kidneys to excrete potassium to maintain cellular balance. This can lead to hypokalemia (low potassium), which paradoxically triggers severe muscle cramps, worsened fatigue, and intense heart palpitations. To combat this, maintaining a 1:1 ratio of sodium to potassium via specialized oral rehydration solutions is highly recommended to stabilize the heart's electrical signaling. You can explore how targeted hydration helps in our guide, Can the Electrolyte/Energy Formula Support Hydration and Focus in Long COVID and ME/CFS?.

In addition to fluid and electrolyte expansion, patients often utilize lower-body compression garments (waist-high, medical-grade compression at 30-40 mmHg is most effective) to physically reduce blood pooling in the legs. When lifestyle modifications are insufficient, providers may prescribe medications like Fludrocortisone, a synthetic hormone that helps the kidneys retain sodium and further expand blood volume, providing a stronger foundation for cardiovascular stability.

When volume expansion alone cannot control the severe tachycardia, pharmacological interventions are introduced to directly calm the hyperactive sympathetic nervous system. Beta-blockers, such as propranolol, bisoprolol, and metoprolol, are the traditional standard of care for hyperadrenergic POTS. These medications work by blocking the effects of adrenaline on the heart, effectively blunting the rapid heart rate spikes and reducing the sensation of palpitations.

A critical caveat in managing Long COVID POTS is that low doses of beta-blockers are often much more effective than high doses. High doses can severely exacerbate Long COVID fatigue, lower blood pressure too much (worsening orthostatic intolerance), and trigger severe lethargy. Providers must carefully titrate these medications to find the 'sweet spot' that controls the heart rate without crushing the patient's energy levels.

For patients whose fatigue is worsened by beta-blockers, Ivabradine has emerged as a highly favored alternative. Ivabradine lowers the heart rate by selectively acting on the sinus node (the heart's natural pacemaker) without lowering blood pressure or inducing systemic fatigue. Studies have demonstrated that Ivabradine is safe and highly effective, showing significant symptom improvement in a large majority of POTS patients who cannot tolerate traditional beta-blockers.

Cardiovascular deconditioning undoubtedly worsens POTS symptoms, making physical reconditioning a core pillar of traditional POTS recovery. However, this is the most controversial and delicate aspect of managing Long COVID POTS. Traditional POTS rehabilitation (like the Levine Protocol) uses a gradual, modified exercise program. But for Long COVID patients who suffer from Post-Exertional Malaise (PEM), standard graded exercise therapy (GET) is actively harmful and can trigger severe, long-lasting neuroimmune crashes.

Current clinical guidelines emphasize that reconditioning in Long COVID must be strictly 'paced' and heavily modified. Patients should never push through fatigue. Instead of traditional cardio, rehabilitation should begin with autonomic nervous system retraining, such as breathing mechanics, vagus nerve stimulation, and vestibular rehabilitation. When physical movement is tolerated, it must be strictly recumbent (lying down)—such as gentle floor stretches or recumbent biking—to avoid fighting gravity. For more on managing this delicate balance, read Heart Rate Spikes in POTS: Why Your Heart Races When You Stand Up.

Living with Long COVID, POTS, and severe heart rate dysregulation is an exhausting, unpredictable journey. It is crucial to remember that the tachycardia, palpitations, and profound fatigue you are experiencing are real, physiological responses to a complex neuro-vascular injury. They are not the result of deconditioning, and they are certainly not 'all in your head.' The scientific community is rapidly uncovering the microscopic mechanisms—from fibrinaloid microclots to rogue autoantibodies—that drive these debilitating symptoms, validating what patients have known all along.

While there is currently no single definitive treatment that resolves Long COVID completely, the symptoms of dysautonomia and POTS are highly manageable with the right targeted approach. By combining strategic fluid and electrolyte expansion, precise pharmacological support, and meticulous pacing to avoid PEM, many patients are able to significantly improve their quality of life and regain functional capacity. The key is working with a healthcare provider who understands the unique nuances of post-viral illness and is willing to tailor management plans to your specific autonomic profile.

If you are struggling to manage your Long COVID symptoms and need specialized, compassionate care, we are here to help. Explore RTHM's clinical approach to complex chronic conditions and discover how our specialized providers can support you on your path forward. Always remember to consult with a healthcare provider before starting or stopping any new medications, supplements, or reconditioning protocols.